| In ZINC since | Heavy atoms | Benign functionality |
|---|---|---|
| October 4th, 2005 | 22 | No |
Popular Name: Quercetin Quercetin
Find On: PubMed — Wikipedia — Google
CAS Numbers: 117-39-5 , 117-39-5, 6151-25-3(hydrate) , 117-39-5; 6151-25-3 , 23746-81-8 , 57-41-0 , 6151-25-3 , 849061-97-8 , [117-39-5] , [6151-25-3]
117-39-5; 3,3',4,5,7-Pentahydroxyflavone; 3,5,7,3',4'-Pentahydroxyflavone; C00389; Quercetin
117-39-5; 3,5,7,3',4'-pentahydroflavone; 3,5,7,3',4'-pentahydroxyflavone; CPD-520; quercetin
2-(3,4-DIHYDROXY-PHENYL)-3,5,7-TRIHYDROXY-CHROMEN-4-ONE
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one dihydrate
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one dihydrate
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one
3',4',5,7-Tetrahydroxyflavan-3-ol
3',4',5,7-tetrahydroxyflavon-3-ol
3,3',4',5,7-Pentahydroxyflavone
3,3',4',5,7-Pentahydroxyflavone dihydrate
3,3',4',5,7-Pentahydroxyflavone, 95%+
3,3',4,5,7-Pentahydroxyflavone
3,5,7,3',4'-Pentahydroxyflavone
3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on
3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one
49643640-FD4C-4B93-BD28-0D7C2021CC52
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-
5-18-05-00494 (Beilstein Handbook Reference)
6151-25-3; Prestwick_541; Quercetine dihydrate
ANISE (PIMPINELLA ANISUM L.); Anise; Anise, common; Aniseed; LS-181756; Pimpinella anisum
CHEBI:45280; CHEBI:14991; CHEBI:8696; CHEBI:11704; CHEBI:26472
Flavone, 3,3',4',5,7-pentahydroxy-
Flavone, 3,4',5,5',7-pentahydroxy-
Quercetin dihydrate [117-39-5]; (3,5,7,3',4'-Pentahydroxyflavone dihydrate)
Quercetin dihydrate (Sophoretin)
Quercetin Dihydrate [6151-25-3]; (3,5,7,3',4'-Pentahydroxyflavone)
Quercetin with HPLC [117-39-5]
Quercetin with HPLC [117-39-5]; (3,5,7,3',4'-Pentahydroxyflavone)
Quercetin [117-39-5]; (3,5,7,3',4'-Pentahydroxyflavone)
Sophoretin, Meletin, Quercetine, Xanthaurine, Quercetol, Quercitin
| Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
|---|---|---|---|---|---|---|---|---|---|---|
| Ref Reference (pH 7) | 1.68 | -2.9 | -13.58 | 5 | 7 | 0 | 131 | 302.238 | 1 | ↓ |
| Mid Mid (pH 6-8) | 1.94 | -2.61 | -43.8 | 4 | 7 | -1 | 134 | 301.23 | 1 | ↓ |
| Note Type | Comments | Provided By |
|---|---|---|
| Molecular_Solubility | 1.619 | Bitter DB |
| mp | 123 - 125 | MolMall (formerly Molecular Diversity Preservation International) |
| ALOGPS_SOLUBILITY | 2.61e-01 g/l | DrugBank-experimental |
| M.P. | 305-312 C | Indofine |
| MP | 305-312o C | Indofine |
| Melting_Point | 310-315? | Alfa-Aesar |
| Melting_Point | 310-315° | Alfa-Aesar |
| mp | 316 | MolMall (formerly Molecular Diversity Preservation International) |
| M.P | 320C | Indofine |
| MP | 320o C | Indofine |
| UniProt Database Links | 3AT1_ARATH; 3AT2_ARATH; 3MAT_DAHPI; AB1B_ARATH; ALD2_SPOSA; ALDX_SPOSA; ANMT_RUTGR; AOXA_RAT; CBR1_HUMAN; CPRC2_CANPA; DHRS4_BOVIN; DHRS4_HUMAN; DHRS4_MOUSE; DHRS4_PIG; DHRS4_PONAB; DHRS4_RABIT; DHRS4_RAT; F3ST_FLABI; F3ST_FLACH; F4ST_FLACH; FAOMT_VITVI | ChEBI |
| Purity | 95% | Fluorochem |
| Purity | 98% | Fluorochem |
| Mp [°C] | >300 | Acros Organics |
| Therapy | capillary protectant | SMDC MicroSource |
| therap | capillary protectant, antioxidant. antineoplastic, anti-HIV | MicroSource Spectrum |
| Patent Database Links | EP1180331; EP1438962; EP1510137; EP1514540; EP1523982; EP1566176; EP1568283; EP1570839; EP1574499; EP1595936; EP1604675; EP1652527; EP1671630; EP1681289; EP1683512; EP1726309; EP1782802; EP1803468; EP1808169; EP1834636; EP1847265; EP1867323; EP1911358; EP | ChEBI |
| H phrase | H301: Toxic if swallowed | Acros Organics |
| Target | Others | Selleck Chemicals |
| P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician | Acros Organics |
| P phrase | P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician; P264: Wash face, hands and any exposed skin thoroughly after handling | Acros Organics |
| Target | Peroxisome proliferator-activated receptor gamma(P37231)&G2/mitotic-specific cyclin-B1(P14635)&Cell division control protein 2 homolog(P06493)&Cyclin-dependent kinase inhibitor 1(P38936)&Retinoblastoma-associated protein(P06400)&Serine/threonine-protein k | Herbal Ingredients Targets |
| Target | PI3K, PKC, Src, Sirtuin | Selleck Chemicals |
| R phrase | R25: Toxic if swallowed. | Acros Organics |
| S phrase | S36/39: Wear suitable protective clothing and eye/face protection. | Acros Organics |
| Hazard | T: Toxic | Acros Organics |
| APPEARANCE | Yellow powder | Indofine |
| M.P. | ~315-318 C (dec) | Indofine |
| Purity | ¡Ý99.0% ( HPLC ) | APIChem |
| Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| AMPC-2-B | Beta-lactamase (cluster #2 Of 6), Bacterial | Bacteria | 4000 | 0.34 | Binding ≤ 10μM |
| AMPH-2-B | Penicillin-binding Protein AmpH (cluster #2 Of 2), Bacterial | Bacteria | 4000 | 0.34 | Binding ≤ 10μM |
| MDH-1-B | Malate Dehydrogenase (cluster #1 Of 1), Bacterial | Bacteria | 6000 | 0.33 | Binding ≤ 10μM |
| NANH-1-B | Sialidase (cluster #1 Of 1), Bacterial | Bacteria | 9800 | 0.32 | Binding ≤ 10μM |
| 5NTD-1-E | 5'-nucleotidase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 45 | 0.47 | Binding ≤ 10μM |
| AA1R-2-E | Adenosine A1 Receptor (cluster #2 Of 4), Eukaryotic | Eukaryotes | 2470 | 0.36 | Binding ≤ 10μM |
| AA2AR-3-E | Adenosine A2a Receptor (cluster #3 Of 4), Eukaryotic | Eukaryotes | 6990 | 0.33 | Binding ≤ 10μM |
| ABCG2-1-E | ATP-binding Cassette Sub-family G Member 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7600 | 0.33 | Binding ≤ 10μM |
| AK1A1-1-E | Aldehyde Reductase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2320 | 0.36 | Binding ≤ 10μM |
| AK1CL-1-E | Aldo-keto Reductase Family 1 Member C21 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6900 | 0.33 | Binding ≤ 10μM |
| ALDR-1-E | Aldose Reductase (cluster #1 Of 5), Eukaryotic | Eukaryotes | 2850 | 0.35 | Binding ≤ 10μM |
| AOFA-4-E | Monoamine Oxidase A (cluster #4 Of 8), Eukaryotic | Eukaryotes | 10 | 0.51 | Binding ≤ 10μM |
| CAH1-12-E | Carbonic Anhydrase I (cluster #12 Of 12), Eukaryotic | Eukaryotes | 2680 | 0.35 | Binding ≤ 10μM |
| CAH12-2-E | Carbonic Anhydrase XII (cluster #2 Of 9), Eukaryotic | Eukaryotes | 9390 | 0.32 | Binding ≤ 10μM |
| CAH13-1-E | Carbonic Anhydrase XIII (cluster #1 Of 7), Eukaryotic | Eukaryotes | 9030 | 0.32 | Binding ≤ 10μM |
| CAH14-4-E | Carbonic Anhydrase XIV (cluster #4 Of 8), Eukaryotic | Eukaryotes | 5410 | 0.34 | Binding ≤ 10μM |
| CAH2-15-E | Carbonic Anhydrase II (cluster #15 Of 15), Eukaryotic | Eukaryotes | 2540 | 0.36 | Binding ≤ 10μM |
| CAH3-6-E | Carbonic Anhydrase III (cluster #6 Of 6), Eukaryotic | Eukaryotes | 8100 | 0.32 | Binding ≤ 10μM |
| CAH4-14-E | Carbonic Anhydrase IV (cluster #14 Of 16), Eukaryotic | Eukaryotes | 7890 | 0.32 | Binding ≤ 10μM |
| CAH5A-6-E | Carbonic Anhydrase VA (cluster #6 Of 10), Eukaryotic | Eukaryotes | 6810 | 0.33 | Binding ≤ 10μM |
| CAH6-8-E | Carbonic Anhydrase VI (cluster #8 Of 8), Eukaryotic | Eukaryotes | 6170 | 0.33 | Binding ≤ 10μM |
| CAH7-8-E | Carbonic Anhydrase VII (cluster #8 Of 8), Eukaryotic | Eukaryotes | 4840 | 0.34 | Binding ≤ 10μM |
| CAH9-11-E | Carbonic Anhydrase IX (cluster #11 Of 11), Eukaryotic | Eukaryotes | 7000 | 0.33 | Binding ≤ 10μM |
| CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 450 | 0.40 | Binding ≤ 10μM |
| CP19A-1-E | Cytochrome P450 19A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 12 | 0.50 | Binding ≤ 10μM |
| CP1B1-1-E | Cytochrome P450 1B1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 77 | 0.45 | Binding ≤ 10μM |
| CSK21-2-E | Casein Kinase II Alpha (cluster #2 Of 3), Eukaryotic | Eukaryotes | 850 | 0.39 | Binding ≤ 10μM |
| CSK2B-3-E | Casein Kinase II Beta (cluster #3 Of 3), Eukaryotic | Eukaryotes | 850 | 0.39 | Binding ≤ 10μM |
| DHB2-1-E | Estradiol 17-beta-dehydrogenase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1540 | 0.37 | Binding ≤ 10μM |
| DRD4-1-E | Dopamine D4 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 8 | 0.52 | Binding ≤ 10μM |
| EGFR-2-E | Epidermal Growth Factor Receptor ErbB1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 900 | 0.38 | Binding ≤ 10μM |
| GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2100 | 0.36 | Binding ≤ 10μM |
| GSK3B-7-E | Glycogen Synthase Kinase-3 Beta (cluster #7 Of 7), Eukaryotic | Eukaryotes | 2100 | 0.36 | Binding ≤ 10μM |
| LGUL-2-E | Glyoxalase I (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.35 | Binding ≤ 10μM |
| LOX12-2-E | Arachidonate 12-lipoxygenase (cluster #2 Of 4), Eukaryotic | Eukaryotes | 440 | 0.40 | Binding ≤ 10μM |
| LOX15-1-E | Arachidonate 15-lipoxygenase (cluster #1 Of 5), Eukaryotic | Eukaryotes | 2200 | 0.36 | Binding ≤ 10μM |
| LOX5-1-E | Arachidonate 5-lipoxygenase (cluster #1 Of 6), Eukaryotic | Eukaryotes | 500 | 0.40 | Binding ≤ 10μM |
| MRP1-1-E | Multidrug Resistance-associated Protein 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.36 | Binding ≤ 10μM |
| NOX4-1-E | NADPH Oxidase 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 680 | 0.39 | Binding ≤ 10μM |
| P85A-2-E | PI3-kinase P85-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| P85B-2-E | PI3-kinase P85-beta Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| PA21B-2-E | Phospholipase A2 Group 1B (cluster #2 Of 3), Eukaryotic | Eukaryotes | 2000 | 0.36 | Binding ≤ 10μM |
| PIM1-1-E | Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 43 | 0.47 | Binding ≤ 10μM |
| PK3CA-2-E | PI3-kinase P110-alpha Subunit (cluster #2 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CB-1-E | PI3-kinase P110-beta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CD-1-E | PI3-kinase P110-delta Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CG-1-E | PI3-kinase P110-gamma Subunit (cluster #1 Of 3), Eukaryotic | Eukaryotes | 3800 | 0.34 | Binding ≤ 10μM |
| Q965D5-1-E | Enoyl-acyl-carrier Protein Reductase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 473 | 0.40 | Binding ≤ 10μM |
| Q965D6-1-E | 3-oxoacyl-acyl-carrier Protein Reductase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5400 | 0.34 | Binding ≤ 10μM |
| Q965D7-2-E | Fatty Acid Synthase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1500 | 0.37 | Binding ≤ 10μM |
| TRY1-1-E | Trypsin I (cluster #1 Of 5), Eukaryotic | Eukaryotes | 7100 | 0.33 | Binding ≤ 10μM |
| XDH-2-E | Xanthine Dehydrogenase (cluster #2 Of 2), Eukaryotic | Eukaryotes | 1200 | 0.38 | Binding ≤ 10μM |
| LOX5-6-E | Arachidonate 5-lipoxygenase (cluster #6 Of 7), Eukaryotic | Eukaryotes | 10000 | 0.32 | Functional ≤ 10μM |
| CP1A1-1-E | Cytochrome P450 1A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 660 | 0.39 | ADME/T ≤ 10μM |
| CP1A2-1-E | Cytochrome P450 1A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 4097 | 0.34 | ADME/T ≤ 10μM |
| CP1B1-1-E | Cytochrome P450 1B1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 23 | 0.49 | ADME/T ≤ 10μM |
| Z102178-2-O | Liver Microsomes (cluster #2 Of 2), Other | Other | 7500 | 0.33 | Functional ≤ 10μM |
| Z102342-1-O | Liver (cluster #1 Of 1), Other | Other | 6000 | 0.33 | Functional ≤ 10μM |
| Z50425-11-O | Plasmodium Falciparum (cluster #11 Of 22), Other | Other | 8900 | 0.32 | Functional ≤ 10μM |
| Z50597-1-O | Rattus Norvegicus (cluster #1 Of 12), Other | Other | 8500 | 0.32 | Functional ≤ 10μM |
| Z80418-2-O | RAW264.7 (Monocytic-macrophage Leukemia Cells) (cluster #2 Of 9), Other | Other | 9600 | 0.32 | Functional ≤ 10μM |
| Z81000-1-O | HT-22 (Hippocampal Cells) (cluster #1 Of 1), Other | Other | 2980 | 0.35 | Functional ≤ 10μM |
| Z81072-1-O | Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other | Other | 5000 | 0.34 | Functional ≤ 10μM |
| R1AB-1-V | Replicase Polyprotein 1ab (cluster #1 Of 1), Viral | Viruses | 8100 | 0.32 | Binding ≤ 10μM |
| Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
|---|---|---|---|---|---|
| 5NTD_RAT | P21588 | 5'-nucleotidase, Rat | 45.3 | 0.47 | Binding ≤ 1μM |
| ALDR_RAT | P07943 | Aldose Reductase, Rat | 1000 | 0.38 | Binding ≤ 1μM |
| ALDR_HUMAN | P15121 | Aldose Reductase, Human | 14.8 | 0.50 | Binding ≤ 1μM |
| LOX12_HUMAN | P18054 | Arachidonate 12-lipoxygenase, Human | 440 | 0.40 | Binding ≤ 1μM |
| LOX15_RABIT | P12530 | Arachidonate 15-lipoxygenase, Rabit | 430 | 0.41 | Binding ≤ 1μM |
| LOX5_RAT | P12527 | Arachidonate 5-lipoxygenase, Rat | 200 | 0.43 | Binding ≤ 1μM |
| LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 790 | 0.39 | Binding ≤ 1μM |
| CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 850 | 0.39 | Binding ≤ 1μM |
| CSK2B_HUMAN | P67870 | Casein Kinase II Beta, Human | 850 | 0.39 | Binding ≤ 1μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 450 | 0.40 | Binding ≤ 1μM |
| CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 12 | 0.50 | Binding ≤ 1μM |
| CP1B1_HUMAN | Q16678 | Cytochrome P450 1B1, Human | 77 | 0.45 | Binding ≤ 1μM |
| DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 7.8 | 0.52 | Binding ≤ 1μM |
| Q965D5_PLAFA | Q965D5 | Enoyl-acyl-carrier Protein Reductase, Plafa | 22 | 0.49 | Binding ≤ 1μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 900 | 0.38 | Binding ≤ 1μM |
| AOFA_BOVIN | P21398 | Monoamine Oxidase A, Bovin | 10 | 0.51 | Binding ≤ 1μM |
| NOX4_HUMAN | Q9NPH5 | NADPH Oxidase 4, Human | 680 | 0.39 | Binding ≤ 1μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 25 | 0.48 | Binding ≤ 1μM |
| Q965D6_PLAFA | Q965D6 | 3-oxoacyl-acyl-carrier Protein Reductase, Plafa | 5400 | 0.34 | Binding ≤ 10μM |
| 5NTD_RAT | P21588 | 5'-nucleotidase, Rat | 45.3 | 0.47 | Binding ≤ 10μM |
| AA1R_RAT | P25099 | Adenosine A1 Receptor, Rat | 2470 | 0.36 | Binding ≤ 10μM |
| AA2AR_RAT | P30543 | Adenosine A2a Receptor, Rat | 6990 | 0.33 | Binding ≤ 10μM |
| AK1A1_RAT | P51635 | Aldehyde Reductase, Rat | 2320 | 0.36 | Binding ≤ 10μM |
| AK1CL_MOUSE | Q91WR5 | Aldo-keto Reductase Family 1 Member C21, Mouse | 6900 | 0.33 | Binding ≤ 10μM |
| ALDR_BOVIN | P16116 | Aldose Reductase, Bovin | 2850 | 0.35 | Binding ≤ 10μM |
| ALDR_RAT | P07943 | Aldose Reductase, Rat | 1000 | 0.38 | Binding ≤ 10μM |
| ALDR_HUMAN | P15121 | Aldose Reductase, Human | 14.8 | 0.50 | Binding ≤ 10μM |
| LOX12_HUMAN | P18054 | Arachidonate 12-lipoxygenase, Human | 440 | 0.40 | Binding ≤ 10μM |
| LOX15_HUMAN | P16050 | Arachidonate 15-lipoxygenase, Human | 2200 | 0.36 | Binding ≤ 10μM |
| LOX15_RABIT | P12530 | Arachidonate 15-lipoxygenase, Rabit | 430 | 0.41 | Binding ≤ 10μM |
| LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 790 | 0.39 | Binding ≤ 10μM |
| LOX5_RAT | P12527 | Arachidonate 5-lipoxygenase, Rat | 200 | 0.43 | Binding ≤ 10μM |
| ABCG2_HUMAN | Q9UNQ0 | ATP-binding Cassette Sub-family G Member 2, Human | 6900 | 0.33 | Binding ≤ 10μM |
| AMPC_ECOLI | P00811 | Beta-lactamase, Ecoli | 4000 | 0.34 | Binding ≤ 10μM |
| CAH1_HUMAN | P00915 | Carbonic Anhydrase I, Human | 2680 | 0.35 | Binding ≤ 10μM |
| CAH2_HUMAN | P00918 | Carbonic Anhydrase II, Human | 2540 | 0.36 | Binding ≤ 10μM |
| CAH3_HUMAN | P07451 | Carbonic Anhydrase III, Human | 8100 | 0.32 | Binding ≤ 10μM |
| CAH4_HUMAN | P22748 | Carbonic Anhydrase IV, Human | 7890 | 0.32 | Binding ≤ 10μM |
| CAH9_HUMAN | Q16790 | Carbonic Anhydrase IX, Human | 7000 | 0.33 | Binding ≤ 10μM |
| CAH5A_HUMAN | P35218 | Carbonic Anhydrase VA, Human | 6810 | 0.33 | Binding ≤ 10μM |
| CAH6_HUMAN | P23280 | Carbonic Anhydrase VI, Human | 6170 | 0.33 | Binding ≤ 10μM |
| CAH7_HUMAN | P43166 | Carbonic Anhydrase VII, Human | 4840 | 0.34 | Binding ≤ 10μM |
| CAH12_HUMAN | O43570 | Carbonic Anhydrase XII, Human | 9390 | 0.32 | Binding ≤ 10μM |
| CAH13_MOUSE | Q9D6N1 | Carbonic Anhydrase XIII, Mouse | 9030 | 0.32 | Binding ≤ 10μM |
| CAH14_HUMAN | Q9ULX7 | Carbonic Anhydrase XIV, Human | 5410 | 0.34 | Binding ≤ 10μM |
| CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 1100 | 0.38 | Binding ≤ 10μM |
| CSK2B_HUMAN | P67870 | Casein Kinase II Beta, Human | 1100 | 0.38 | Binding ≤ 10μM |
| CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 450 | 0.40 | Binding ≤ 10μM |
| CP19A_HUMAN | P11511 | Cytochrome P450 19A1, Human | 12 | 0.50 | Binding ≤ 10μM |
| CP1B1_HUMAN | Q16678 | Cytochrome P450 1B1, Human | 77 | 0.45 | Binding ≤ 10μM |
| DRD4_HUMAN | P21917 | Dopamine D4 Receptor, Human | 7.8 | 0.52 | Binding ≤ 10μM |
| Q965D5_PLAFA | Q965D5 | Enoyl-acyl-carrier Protein Reductase, Plafa | 1090 | 0.38 | Binding ≤ 10μM |
| EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 900 | 0.38 | Binding ≤ 10μM |
| DHB2_HUMAN | P37059 | Estradiol 17-beta-dehydrogenase 2, Human | 1540 | 0.37 | Binding ≤ 10μM |
| Q965D7_PLAFA | Q965D7 | Fatty Acid Synthase, Plafa | 1500 | 0.37 | Binding ≤ 10μM |
| GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 2100 | 0.36 | Binding ≤ 10μM |
| GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 2100 | 0.36 | Binding ≤ 10μM |
| LGUL_HUMAN | Q04760 | Glyoxalase I, Human | 3200 | 0.35 | Binding ≤ 10μM |
| MDH_THETH | P10584 | Malate Dehydrogenase, Theth | 6000 | 0.33 | Binding ≤ 10μM |
| AOFA_BOVIN | P21398 | Monoamine Oxidase A, Bovin | 10 | 0.51 | Binding ≤ 10μM |
| AOFA_HUMAN | P21397 | Monoamine Oxidase A, Human | 2800 | 0.35 | Binding ≤ 10μM |
| MRP1_HUMAN | P33527 | Multidrug Resistance-associated Protein 1, Human | 2400 | 0.36 | Binding ≤ 10μM |
| NOX4_HUMAN | Q9NPH5 | NADPH Oxidase 4, Human | 680 | 0.39 | Binding ≤ 10μM |
| AMPH_ECOLI | P0AD70 | Penicillin-binding Protein AmpH, Ecoli | 4000 | 0.34 | Binding ≤ 10μM |
| PA21B_HUMAN | P04054 | Phospholipase A2 Group 1B, Human | 2000 | 0.36 | Binding ≤ 10μM |
| PK3CA_HUMAN | P42336 | PI3-kinase P110-alpha Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CB_HUMAN | P42338 | PI3-kinase P110-beta Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CD_HUMAN | O00329 | PI3-kinase P110-delta Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| PK3CG_HUMAN | P48736 | PI3-kinase P110-gamma Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| P85A_HUMAN | P27986 | PI3-kinase P85-alpha Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| P85B_HUMAN | O00459 | PI3-kinase P85-beta Subunit, Human | 3800 | 0.34 | Binding ≤ 10μM |
| R1AB_CVHSA | P0C6X7 | Replicase Polyprotein 1ab, Cvhsa | 8100 | 0.32 | Binding ≤ 10μM |
| PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 1100 | 0.38 | Binding ≤ 10μM |
| NANH_CLOPE | P10481 | Sialidase, Clope | 1700 | 0.37 | Binding ≤ 10μM |
| TRY1_HUMAN | P07477 | Trypsin I, Human | 7100 | 0.33 | Binding ≤ 10μM |
| XDH_HUMAN | P47989 | Xanthine Dehydrogenase, Human | 2620 | 0.36 | Binding ≤ 10μM |
| XDH_BOVIN | P80457 | Xanthine Dehydrogenase, Bovin | 1200 | 0.38 | Binding ≤ 10μM |
| LOX5_RAT | P12527 | Arachidonate 5-lipoxygenase, Rat | 10000 | 0.32 | Functional ≤ 10μM |
| LOX5_HUMAN | P09917 | Arachidonate 5-lipoxygenase, Human | 3000 | 0.35 | Functional ≤ 10μM |
| Z81000 | Z81000 | HT-22 (Hippocampal Cells) | 2980 | 0.35 | Functional ≤ 10μM |
| Z81072 | Z81072 | Jurkat (Acute Leukemic T-cells) | 5000 | 0.34 | Functional ≤ 10μM |
| Z102342 | Z102342 | Liver | 1800 | 0.37 | Functional ≤ 10μM |
| Z102178 | Z102178 | Liver Microsomes | 7500 | 0.33 | Functional ≤ 10μM |
| Z50425 | Z50425 | Plasmodium Falciparum | 2511.88643 | 0.36 | Functional ≤ 10μM |
| Z50597 | Z50597 | Rattus Norvegicus | 10000 | 0.32 | Functional ≤ 10μM |
| Z80418 | Z80418 | RAW264.7 (Monocytic-macrophage Leukemia Cells) | 9600 | 0.32 | Functional ≤ 10μM |
| CP1A1_HUMAN | P04798 | Cytochrome P450 1A1, Human | 1191 | 0.38 | ADME/T ≤ 10μM |
| CP1A2_HUMAN | P05177 | Cytochrome P450 1A2, Human | 4097 | 0.34 | ADME/T ≤ 10μM |
| CP1B1_HUMAN | Q16678 | Cytochrome P450 1B1, Human | 23 | 0.49 | ADME/T ≤ 10μM |
| Description | Species |
|---|---|
| Abacavir transmembrane transport | |
| ABC-family proteins mediated transport | |
| Activation of Matrix Metalloproteinases | |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
| Acyl chain remodelling of PC | |
| Acyl chain remodelling of PE | |
| Acyl chain remodelling of PG | |
| Acyl chain remodelling of PI | |
| Acyl chain remodelling of PS | |
| Adenosine P1 receptors | |
| Aflatoxin activation and detoxification | |
| AKT phosphorylates targets in the cytosol | |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
| APC truncation mutants have impaired AXIN binding | |
| APC/C:Cdc20 mediated degradation of Cyclin B | |
| Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2 | |
| AXIN missense mutants destabilize the destruction complex | |
| Beta-catenin phosphorylation cascade | |
| CD28 dependent PI3K/Akt signaling | |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | |
| Condensation of Prometaphase Chromosomes | |
| Condensation of Prophase Chromosomes | |
| Constitutive PI3K/AKT Signaling in Cancer | |
| Costimulation by the CD28 family | |
| CRMPs in Sema3A signaling | |
| Cyclin A/B1 associated events during G2/M transition | |
| Cyclin B2 mediated events | |
| DAP12 signaling | |
| Degradation of beta-catenin by the destruction complex | |
| Depolymerisation of the Nuclear Lamina | |
| disassembly of the destruction complex and recruitment of AXIN to the membrane | |
| Dopamine receptors | |
| Downstream signal transduction | |
| Downstream TCR signaling | |
| E2F mediated regulation of DNA replication | |
| E2F-enabled inhibition of pre-replication complex formation | |
| EGFR downregulation | |
| EGFR interacts with phospholipase C-gamma | |
| EGFR Transactivation by Gastrin | |
| Endogenous sterols | |
| Enzymatic degradation of dopamine by COMT | |
| Enzymatic degradation of Dopamine by monoamine oxidase | |
| ERK1 activation | |
| Erythrocytes take up carbon dioxide and release oxygen | |
| Erythrocytes take up oxygen and release carbon dioxide | |
| Estrogen biosynthesis | |
| G alpha (12/13) signalling events | |
| G alpha (i) signalling events | |
| G alpha (q) signalling events | |
| G alpha (s) signalling events | |
| G beta:gamma signalling through PI3Kgamma | |
| G0 and Early G1 | |
| G1/S-Specific Transcription | |
| G2/M DNA replication checkpoint | |
| GAB1 signalosome | |
| Golgi Cisternae Pericentriolar Stack Reorganization | |
| GP1b-IX-V activation signalling | |
| GPVI-mediated activation cascade | |
| GRB2 events in EGFR signaling | |
| GRB2 events in ERBB2 signaling | |
| Interleukin receptor SHC signaling | |
| Interleukin-3, 5 and GM-CSF signaling | |
| Interleukin-7 signaling | |
| Iron uptake and transport | |
| Loss of Nlp from mitotic centrosomes | |
| Loss of proteins required for interphase microtubule organization from the ce | |
| MASTL Facilitates Mitotic Progression | |
| Metabolism of serotonin | |
| Methylation | |
| misspliced GSK3beta mutants stabilize beta-catenin | |
| Monoamines are oxidized to aldehydes by MAOA and MAOB, producing NH3 and H2O2 | |
| Nephrin interactions | |
| NGF-independant TRKA activation | |
| Norepinephrine Neurotransmitter Release Cycle | |
| Nuclear Pore Complex (NPC) Disassembly | |
| Phosphorylation of Emi1 | |
| Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
| Phosphorylation of the APC/C | |
| PI-3K cascade | |
| PI3K Cascade | |
| PI3K events in ERBB2 signaling | |
| PI3K events in ERBB4 signaling | |
| PI3K/AKT activation | |
| PIP3 activates AKT signaling | |
| PLCG1 events in ERBB2 signaling | |
| PPARA activates gene expression | |
| Pregnenolone biosynthesis | |
| Purine catabolism | |
| Recruitment of mitotic centrosome proteins and complexes | |
| Recruitment of NuMA to mitotic centrosomes | |
| Regulation of APC/C activators between G1/S and early anaphase | |
| Regulation of gene expression by Hypoxia-inducible Factor | |
| Regulation of HSF1-mediated heat shock response | |
| Regulation of PLK1 Activity at G2/M Transition | |
| Regulation of signaling by CBL | |
| Resolution of Sister Chromatid Cohesion | |
| Retinoid metabolism and transport | |
| Reversible hydration of carbon dioxide | |
| Rho GTPase cycle | |
| Role of LAT2/NTAL/LAB on calcium mobilization | |
| Role of phospholipids in phagocytosis | |
| S33 mutants of beta-catenin aren't phosphorylated | |
| S37 mutants of beta-catenin aren't phosphorylated | |
| S45 mutants of beta-catenin aren't phosphorylated | |
| SHC1 events in EGFR signaling | |
| SHC1 events in ERBB2 signaling | |
| Signal transduction by L1 | |
| Signaling by constitutively active EGFR | |
| Signaling by EGFR | |
| Signaling by ERBB2 | |
| Signaling by ERBB4 | |
| Signaling by FGFR mutants | |
| Signaling by FGFR1 fusion mutants | |
| Signaling by SCF-KIT | |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | |
| Synthesis of 12-eicosatetraenoic acid derivatives | |
| Synthesis of 15-eicosatetraenoic acid derivatives | |
| Synthesis of 5-eicosatetraenoic acids | |
| Synthesis of bile acids and bile salts via 24-hydroxycholesterol | |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | |
| Synthesis of Hepoxilins (HX) and Trioxilins (TrX) | |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | |
| Synthesis of Lipoxins (LX) | |
| Synthesis of PA | |
| Synthesis of PIPs at the plasma membrane | |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | |
| T41 mutants of beta-catenin aren't phosphorylated | |
| Tie2 Signaling | |
| truncations of AMER1 destabilize the destruction complex | |
| VEGFA-VEGFR2 Pathway | |
| WNT mediated activation of DVL | |
| XBP1(S) activates chaperone genes | |
| Xenobiotics |
